12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ADXS-HPV: Additional Phase II data

Updated preliminary data from an Indian Phase II trial in 110 women with recurrent or refractory cervical cancer showed that IV ADXS-HPV with or without cisplatin produced 6 complete responses, 6 partial response with a >=30% reduction in tumor burden and 33 cases of...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >